TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
IBIO

iBio, Inc.

Healthcare · Biotechnology

0.92$ -8.9% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

iBio, Inc. (IBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 99 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IBIO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
48 44 41 36 33 35 31 43 43 40 36 31 35 36 42 94 117 145 143 147 144 126 115 99 85 52 44 41 38 34 50 29 25 22 19 23 64 64 86 99
20 17 13 8.6 6.4 7.8 4.0 16 16 14 9.6 4.8 2.4 4.0 10 62 85 111 107 105 90 67 60 45 64 38 27 26 23 20 36 16 12 8.3 6.1 9.7 51 53 77 92
20 16 12 8.1 5.9 7.3 3.4 16 16 13 9.0 4.4 2.1 3.6 10 55 78 91 85 77 63 39 34 23 9.9 3.7 6.6 7.3 1.5 2.8 5.3 14 11 7.0 5.0 8.6 28 29 48 56
20 16 12 8.1 5.9 7.3 3.4 16 16 13 9.0 4.4 2.1 3.6 10 55 84 108 104 97 82 57 49 – 17 9.6 6.6 7.3 1.5 2.8 5.3 14 11 7.0 5.0 8.6 50 53 75 88
0.2 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 5.6 0.3 0.2 0.4 5.5 5.3 5.2 6.1 1.0 6.2 7.7 1.2 0.2 – 1.8 14 0.7 – 0.0 – 0.1 0.1 0.0 0.0 1.1
0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – 0.8 0.8 1.1 0.4 0.0 0.6 2.0 3.3 3.9 3.9 20 18 21 – 14 – – – – – – – – – –
26 25 26 26 25 25 25 25 25 25 25 24 2.6 2.7 2.7 3.7 3.8 5.0 33 35 9.8 38 40 42 7.3 7.9 – 7.6 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
2.0 2.0 1.9 1.8 1.8 1.7 1.7 1.6 1.6 1.5 1.4 1.4 1.3 1.2 1.2 1.1 1.2 1.2 1.1 1.0 5.2 5.0 4.9 4.9 6.0 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4 6.1 6.1 6.8 6.8 4.3 1.8 1.8
27 27 28 27 27 27 27 27 30 29 29 28 37 37 38 38 37 38 38 38 43 36 36 36 36 33 27 26 24 25 25 7.4 6.8 7.8 7.7 8.3 8.1 7.8 8.3 13
2.2 1.9 2.6 2.0 2.1 2.0 1.9 2.0 5.0 4.4 4.0 3.5 4.9 4.7 6.2 5.2 5.0 6.1 6.1 6.6 8.1 8.3 8.3 30 32 28 22 22 21 22 21 3.8 3.5 4.7 5.4 6.1 6.0 5.9 6.5 12
0.3 0.4 0.4 0.4 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 1.5 0.3 0.7 0.8 0.9 1.0 0.5 0.2 0.1 – 23 17 14 14 13 14 14 1.0 1.0 0.9 1.4 1.3 1.2 0.5 0.5 0.5
0.7 0.6 1.4 0.3 0.5 0.7 0.8 0.8 0.7 0.6 0.7 1.0 0.7 0.4 0.5 2.9 1.6 2.4 1.6 2.3 2.3 2.7 5.3 4.3 4.8 4.0 2.0 1.8 1.9 1.9 1.2 0.4 0.9 0.6 1.5 2.2 2.8 2.7 3.0 4.4
25 25 25 25 25 25 25 25 25 – – – – – – 0.3 0.2 0.1 0.0 – – 22 22 – – – – – – – 0.8 0.8 0.7 0.6 – – – – – –
7.1 4.2 13 8.9 6.3 7.8 4.2 16 13 11 6.9 2.5 -1.9 -0.5 4.0 57 80 107 105 109 101 91 79 63 48 19 17 15 13 9.2 25 21 18 14 11 15 56 57 78 86
-61 -64 -68 -72 -76 -80 -84 -88 -93 -97 -101 -106 -110 -136 -147 -150 -158 -166 -174 -174 -183 -194 -207 -224 -242 -276 -283 -289 -295 -303 -306 -314 -318 -322 -327 -332 -338 -347 -355 -365
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 140 0.3 0.4 0.4 0.4 0.4 0.4 0.4 8.7 0.4 0.5 0.7 1.0 1.2 1.9 3.7 8.6 8.6 9.1 9.9 16 53 99 120 104

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?